REDEFINING VASCULAR INTERVENTIONS
Corindus, A Siemens Healthineers Company, is a global technology leader in robotic-assisted vascular interventions. Our CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the second-generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically.
technIQ Performance in a ModelSpin Automation Demonstrated in a Type B2 Lesion in a Coronary Flow Model
WITH SPIN AUTOMATION
* technIQ series 2 is currently under development; it is not for sale in the U.S.A. Its future availability cannot be guaranteed. CE Mark granted, 510(k) pending
¹ Madder R, et al. 2017. Disclaimers: Compared to robotic wiring without automation, preclinical study data may not be predictive of clinical results